Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic

The American Journal of Gastroenterology
Shubha BhatAlan C Moss

Abstract

To characterize the clinical pharmacists' impact on caring for patients with inflammatory bowel disease during COVID-19. A clinical pharmacist's encounters between March 17 and April 14, 2020, were audited to determine encounter frequency and indication. The clinical pharmacist addressed COVID-19 and inflammatory bowel disease treatment concerns with 140 patients, conducted 34 medication education and monitoring visits, reviewed 141 patients' charts and helped rescheduled 18 patients who missed their biologic infusion, transitioned 12 patients to home infusions, and assisted 5 patients with medication access. Clinical pharmacists embedded in gastroenterology practices permit for continued optimal patient care during a pandemic.

References

Feb 13, 2019·Inflammatory Bowel Diseases·Shubha BhatFrancis A Farraye
Mar 28, 2020·Nature Reviews. Gastroenterology & Hepatology·Silvio DaneseAntonino Spinelli
Apr 19, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Mariangela AlloccaSilvio Danese

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

© 2021 Meta ULC. All rights reserved